Drug intelligence / Profile preview

Livitol-70

Development stage
Preclinical
Lead developer
Composite Interceptive Med-Science Laboratories
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Livitol-70 is a herbal medicine developed as an antioxidant supplement intended to improve hepatic function in patients with alcoholic liver disease who do not have cirrhosis. It is formulated from three whole herbs and their extracts, which are reported to possess antioxidant, hepatoprotective (liver-protecting), and reno-protective (kidney-protecting) properties. The product is being studied for its efficacy in improving liver function among individuals with alcohol-induced liver damage. Its mechanism of action centers on reducing oxidative stress and supporting hepatic health through the combined effects of its herbal components[1].

Brand names
Livitol-70Livitol70Livitol 70Livitol-17Livitol17Livitol 17
Other names
Livitol-70Livitol70Livitol 70Livitol-17Livitol17Livitol 17

Beyond the preview

Go deeper on Livitol-70.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Livitol-70.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call